FDA/USP meeting on Treatment INDs
Executive Summary
On May 3, FDA Associate Commissioner for Health Affairs Stuart Nightingale, MD, met with U.S. Pharmacopeial Executive Director Jerome Halperin and two members of the USP Board of Trustees to discuss how USP can help FDA to announce the availability of and information on Treatment IND drugs. USP agreed to publish the information in a new index to volume one of the USP DI, information compendium that goes to pharmacists, physicians and hospitals.